FDA Says Some Insulin Pumps Vulnerable to Fatal Cyber Threats

The Food and Drug Administration (FDA) warned patients and health care providers using certain types of insulin pumps of cyber threats involving the devices, with the pumps recalled due to vulnerabilities that could lead to fatal consequences for users. Security researchers found cyber vulnerabilities in certain types of Medtronic MiniMed insulin pumps that enabled unauthorized users to access the pumps if they are connected to WiFi and alter or stop the amount of insulin delivered to a patient.

The GigaLaw Firm helps companies of all sizes protect their brands online, using domain name dispute policies – such as the Uniform Domain Name Dispute Resolution Policy (UDRP) – and other legal tools available to copyright and trademark owners on the Internet.